Literature DB >> 11191637

A study of iodothyronine 5'-monodeiodinase activities in normal and pathological tissues in man and their comparison with activities in rat tissues.

L Sabatino1, G Iervasi, P Ferrazzi, D Francesconi, I J Chopra.   

Abstract

The present study was undertaken to investigate the peripheral iodothyronine 5'-monodeiodination in different human and rat tissues. We studied iodothyronine 5'-monodeiodinase type I (5'-DI) activity in liver, kidney, intestine, right cardiac atrium and skeletal muscle and we compared the results with those in rat tissues. Lodothyronine 5'- monodeiodinase type II (5'-DII) activity was studied in normal and ischemic human heart and in rat normal myocardium and brain. The 5'-DI activity (fmol/min x mg protein) in liver and kidney was significantly higher (p < 0.001, ANOVA) in normal rat tissue than in human. However, no significant differences were observed in 5'-DI activity between normal and tumoral human intestine or between intestinal tissue of man and rat. 5'-DI activity in normal human skeletal muscle was significantly higher than that in rat skeletal muscle (p < 0.05). The 5'-DI activity was lower in human ischemic myocardium when compared to normal myocardium either in humans (p < 0.05) or rat (p < 0.001). The Km of 5'-DI was significantly lower in rat than in human kidney and liver (p < 0.05). We conclude that 1) 5'-DI is distributed widely among extrathyroidal human and rat tissues and 5'-DII activity is detectable both in human and rat heart; 2) 5'-DI activity in liver and kidney is lower in man than in rat; 3) 5'-DI activity in the skeletal muscle is higher in man than in the rat; 4) 5'-DI activity is decreased in tumoral tissues of human liver and kidney and in ischemic myocardium, while no significant difference was found between human and rat cardiac 5'-DII activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11191637     DOI: 10.1016/s0024-3205(00)00929-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  17 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

Review 2.  The menace of endocrine disruptors on thyroid hormone physiology and their impact on intrauterine development.

Authors:  George Mastorakos; Eftychia I Karoutsou; Maria Mizamtsidi; George Creatsas
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

Review 3.  The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence.

Authors:  E Galli; A Pingitore; G Iervasi
Journal:  Heart Fail Rev       Date:  2008-12-27       Impact factor: 4.214

Review 4.  Paradigms of Dynamic Control of Thyroid Hormone Signaling.

Authors:  Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

5.  Halogenated phenolic contaminants inhibit the in vitro activity of the thyroid-regulating deiodinases in human liver.

Authors:  Craig M Butt; Dongli Wang; Heather M Stapleton
Journal:  Toxicol Sci       Date:  2011-05-11       Impact factor: 4.849

6.  Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones.

Authors:  Laura Sabatino; Valter Lubrano; Silvana Balzan; Claudia Kusmic; Serena Del Turco; Giorgio Iervasi
Journal:  Mol Cell Biochem       Date:  2014-10-11       Impact factor: 3.396

Review 7.  Iodothyronine deiodinases and cancer.

Authors:  A Piekiełko-Witkowska; A Nauman
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

8.  Type I 5'-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma.

Authors:  J Pachucki; M Ambroziak; Z Tanski; J Luczak; J Nauman; A Nauman
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

Review 9.  Does microbiota composition affect thyroid homeostasis?

Authors:  Camilla Virili; Marco Centanni
Journal:  Endocrine       Date:  2014-12-17       Impact factor: 3.633

Review 10.  Cardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or part of the problem?

Authors:  Christine J Pol; Alice Muller; Warner S Simonides
Journal:  Heart Fail Rev       Date:  2010-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.